Kronos Bio Stock In The News

KRON Stock  USD 0.98  0.02  2.00%   
Our overall analysis of Kronos Bio's news coverage and content from conventional and social sources shows investors' bearish mood towards Kronos Bio. The specific impact of Kronos Bio news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Kronos Bio's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Kronos Bio headlines in addition to utilizing other, more conventional financial analysis modules. Check out Kronos Bio Backtesting and Kronos Bio Hype Analysis.
To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.

Kronos Bio Today Top News and Investor Outlook

Yahoo News
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
https://finance.yahoo.com/news/kronos-bio-implements-leadership-structure-130000359.html
 Bullish
Yahoo News
We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
https://finance.yahoo.com/news/were-keeping-eye-kronos-bios-105502314.html
 Neutral
Yahoo News
Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development Candidate
https://finance.yahoo.com/news/kronos-bio-announces-pipeline-p300-210600182.html
 Neutral
Yahoo News
Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
https://finance.yahoo.com/news/kronos-bio-announces-participation-h-130000535.html
 Neutral
Macroaxis News: globenewswire.com
Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/27/2786515/0/en/Kronos-Bio-Announces-Participation-in-35th-Annual-Piper-Sandler-Healthcare-Conference.html
 Neutral
Yahoo News
Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare Conference
https://finance.yahoo.com/news/kronos-bio-announces-participation-35th-210500279.html
 Neutral
Yahoo News
Kronos Bio Up 47%, Insider Buyers Are Up 31%
https://finance.yahoo.com/news/kronos-bio-47-insider-buyers-131804811.html
 Bullish
Yahoo News
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Lags Revenue Estimates
https://finance.yahoo.com/news/kronos-bio-inc-kron-reports-222503153.html
 Bullish
Yahoo News
Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results
https://finance.yahoo.com/news/kronos-bio-reports-recent-business-210500573.html
 Neutral
Macroaxis News: globenewswire.com
Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial Results
https://www.globenewswire.com/news-release/2023/11/13/2779455/0/en/Kronos-Bio-Reports-Recent-Business-Progress-and-Third-Quarter-2023-Financial-Results.html
 Neutral

Kronos Bio Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Kronos and other traded companies coverage with news coverage. We help investors stay connected with Kronos headlines for the 26th of February to make an informed investment decision based on correlating the impacts of news items on Kronos Stock performance. Please note that trading solely based on the Kronos Bio hype is not for everyone as timely availability and quick action are needed to avoid losses.
Kronos Bio's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Kronos Bio investors visualize upcoming and past events in order to time the market based on Kronos Bio noise-free hype analysis.
Kronos Bio stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Kronos earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Kronos Bio that are available to investors today. That information is available publicly through Kronos media outlets and privately through word of mouth or via Kronos internal channels. However, regardless of the origin, that massive amount of Kronos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kronos Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kronos Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kronos Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kronos Bio alpha.

Kronos Largest EPS Surprises

Earnings surprises can significantly impact Kronos Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-11
2024-09-30-0.28-0.230.0517 
2021-05-11
2021-03-31-0.43-0.48-0.0511 
2023-08-08
2023-06-30-0.46-0.52-0.0613 
2024-08-08
2024-06-30-0.34-0.270.0720 
2022-11-08
2022-09-30-0.65-0.570.0812 
2024-03-21
2023-12-31-0.52-0.430.0917 
View All Earnings Estimates

Kronos Bio Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Kronos Bio Stock. The global stock market is bearish. About 62% of major world exchanges and indexes are down. See today's market update for more information.
Yahoo News
28th of January 2025
French Oil Clan Diversifies Into Luxury Real Estate and Diamonds
at finance.yahoo.com 
Macroaxis News
24th of January 2025
Acquisition by Frisbee Allison of 72900 shares of Kronos Bio at 0.96 subject to Rule 16b-3
at MacroaxisInsider 
insidermonkey News
23rd of December 2024
Kronos Worldwide, Inc. Among the Biggest Dividend Cuts and Suspensions of 2024
at insidermonkey.com 
Yahoo News
16th of December 2024
At US10.27, Is Kronos Worldwide, Inc. Worth Looking At Closely
at finance.yahoo.com 
Google News at Macroaxis
6th of December 2024
Kronos Bio Trading 8.5 percent Higher - Heres Why - MarketBeat
at news.google.com 
Gurufocus Stories at Macroaxis
2nd of December 2024
Kronos Worldwide Inc Shares Down 5.84 percent on Dec 2
at gurufocus.com 
Investing News at Macroaxis
27th of November 2024
Kronos Bio announces layoffs and executive changes
at investing.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kronos Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kronos Bio's short interest history, or implied volatility extrapolated from Kronos Bio options trading.
When determining whether Kronos Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kronos Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kronos Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kronos Bio Stock:
Check out Kronos Bio Backtesting and Kronos Bio Hype Analysis.
To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.43)
Revenue Per Share
0.166
Quarterly Revenue Growth
1.585
Return On Assets
(0.25)
Return On Equity
(0.59)
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.